Gene immunization of mice with plasmid DNA expressing rabies virus glycoprotein

Acta Veterinaria Hungarica

Volumn 48, Issue 2, 2000, Pages 229-236

  Fodor, I ^a,b   Kucsera, L ^c   Fodor, Nadja ^a   Palfi V ^d   Grabko, V I ^e,f  

^a SZENT ISTVÁN UNIVERSITY   (Hungary)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Stt Contr Inst for Vet Biol   (Hungary)

^d CENTRAL VETERINARY INSTITUTE   (Hungary)

^e RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

^f SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

Antigen; DNA vaccine; Protection; Rabies; Recombinant DNA

Indexed keywords

DNA VACCINE; GLYCOPROTEIN; GLYCOPROTEIN G, RABIES VIRUS; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; FEMALE; GENETICS; IMMUNIZATION; IMMUNOLOGY; MOUSE; PLASMID; RABIES; RABIES VIRUS;

ANIMALS; ANTIGENS, VIRAL; FEMALE; GLYCOPROTEINS; IMMUNIZATION; MICE; MICE, INBRED BALB C; PLASMIDS; RABIES; RABIES VIRUS; VACCINES, DNA; VIRAL ENVELOPE PROTEINS;

EID: 0034570362     PISSN: 02366290     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Anilionis, A., Wunner, W. H. and Curtis, P. J. (1981): Structure of the glycoprotein gene in rabies virus. Nature 294, 275-278.
2. Benmansour, A., Brahimi, M., Tuffereau, C., Coulon, P., Lafay, M. and Flamand, A. (1992): Rapid sequence evolution of street rabies glycoprotein is related to the highly heterogeneous nature of the viral population. Virology 187, 33-45.
3. Bunschoten, H., Gore, M., Claasen, I. J., Uytdehaag, F. G., Dietzschold, B., Wunner, W. H. and Osterhaus, A. D. (1989): Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein. J. Gen. Virol. 70, 291-298.
4. Chattergoon, M., Boyer, J. and Weiner, D. B. (1997): Genetic immunization: A new era in vaccines and immune therapeutics. FASEB J. 10, 753-763.
5. Conzelmann, K. K., Cox, J. H., Schneider, L. G. and Thiel, H. J. (1990): Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19. Virology 175, 485-489.
6. Coulon, P., Rollin, P. E. and Flamand, A. (1982): Molecular basis of rabies virulence. I. Selection of avirulent mutants of the CVS strain with anti-G monoclonal antibodies. J. Gen. Virol. 61, 97-100.
7. Coulon, P., Rollin, P. E. and Flamand, A. (1983): Molecular basis of rabies virulence. I. Identification of a site on the CVS glycoprotein associated with virulence. J. Gen. Virol. 64, 693-696.
8. Cox, G. J. M., Zamb, T. J. and Babiuk, L. A. (1993): Bovine herpesvirus 1 immune responses in mice and cattle injected with plasmid DNA. J. Virol. 67, 5664-5667.
9. Davis, H. L., McCluskie, M. J., Gerin, J. L. and Purcell, R. H. (1996): DNA vaccine for hepatitis B: Evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc. Nati. Acad. Sci. USA 93, 7213-7218.
10. Dietzschold, B., Wunner, W. H., Wiktor, T. J., Lopez, A. D., Lafon, M., Smith, M. and Koprowski, H. (1983): Characterization of an antigen determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc. Natl. Acad. Sci. USA 80, 70-74.
11. Fodor, I., Grabko, V. I., Khozinski, V. V. and Selimov, M. A. (1994): Nucleotide and deduced amino sequences of the glycoprotein gene of rabies virus vaccine strain Vnukovo-32. Arch. Virol. 135, 451-459.
12. Fodor, I., Horváth, E., Fodor, N., Nagy, E., Rencendorsh, A., Vakharia, V. N. and Dube, S. K. (1999): Induction of protective immunity in chickens immunized with plasmid DNA encoding infectious bursal disease virus. Acta Vet. Hung. 47, 481-492.
13. Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C. and Robinson, H. L. (1993): DNA vaccination: protective immunization by parental, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA 90, 11478-11482.
14. Grabko, V. I., Fodor, I., Selimov, M. A., Khozinski, V. V. and Aksenova, T. A. (1994): Synthesis of functionally active gene of the glycoprotein-G of rabies virus strain Vnukovo-32 by polymerase chain reaction method (PCR). Dokl. Akad. Nauk (Moscow) 337, 117-121.
15. Grassi, M., Wandelerm, A. I. and Peterhans, E. (1989): Enzyme-linked immunosorbent assay for determination of antibodies to the envelope glycoprotein of rabies virus. J. Clin. Microbiol. 27, 899-902.
16. Kucsera, L., Timiryasova, T., Grabko, V. I., Fodor, N., Khozinski, V., Pálfi, V., Selimov, M. A. and Fodor, I. (1997): Immunological and protection studies of vaccinia- and plasmid-vectored recombinant glycoprotein of rabies virus. In: Proceedings of the Meeting: Molecular Biology and Biotechnology for Development. ICGEB, Trieste, Italy, pp. 44-46.
17. Kuklin, N., Daheshia, M., Karern, K., Manickan, E. and Rouse, B. T. (1997): Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Virol. 71, 3138-3145.
18. Ledley, F. D. (1995): Nonviral gene therapy: the promise of genes as pharmaceutical products. Human Gene Therapy 6, 1129-1144.
19. Major, M. E., Vitvitski, L., Mink, M. A., Schleef, M., Whalen, R. G., Trepo, C. and Inchauspe, G. (1995): DNA-based immunization with chimeric vectors for the induction of immune responses against the Hepatitis C virus nucleocapsid. J. Virol. 69, 5798-5805.
20. Montgomery, D. L., Shiver, J. W., Leander, K. R., Perry, H. C., Friedman, A., Martinez, D., Ulmer, J. B., Donnelly, J. J. and Liu, M. A. (1993): Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol. 12, 777-783.
21. Morimoto, K., Ohkubo, A. and Kawai, A. (1989): Structure and transcription of the glycoprotein gene of attenuated HEP-Flury strain of rabies virus. Virology 173, 465-477.
22. Prehaud, C., Takehara, K., Flamand, A. and Bishop, D. H. L. (1989): Immunogenic and protective properties of rabies virus glycoprotein expressed by baculovirus vectors. Virology 173, 390-399.
23. Prevec, L., Campbell, J. B., Christie, B. S., Belbeck, L. and Graham, F. L. (1990): A recombinant human adenovirus vaccine against rabies. J. Infect. Dis. 161, 27-30.
24. Ray, N. B., Ewalt, L. C. and Lodmell, D. L. (1997): Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection. Vaccine 15, 892-895.
25. Ruprecht, C. E. and Kieny, M.-P. (1988): Development of a vaccinia-rabies glycoprotein recombinant virus vaccine. In: Campbell, J. B. and Charlton, K. M. (eds) Rabies. Kluwer Academic, Boston, pp. 335-380.
26. Seif, I., Coulon, P., Rollin, P. E. and Flamand, A. (1985): Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J. Virol. 53, 926-934.
27. Selimov, M. A. (1978): Rabies (in Russian). Nauka, Moscow.
28. Sheay, W., Nelson, S., Martinez, I., Chu, T-H. T., Bhatia, S. and Dornburg, R. (1993): Downstream insertion of the adenovirus tripartite leader sequence enhances expression in universal eukaryotic vectors. Biotechniques 15, 856-862.
29. Tordo, N., Poch, O., Ermine, A., Keith, G. and Rougeon, F. (1986): Walking along the rabies genome: is the large G-L intergenic region a remnant gene? Proc. Natl. Acad. Sci. USA 83, 3914-3918.
30. Wang, B., Ugen, K. E., Srikantan, V., Agadjanyan, M. G., Dang, K., Refaeli, Y., Sato, A. I., Boyer, J., Williams, W. V. and Weiner, D. B. (1993): Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90, 4156-4160.
31. Whalen, R. G. (1996): DNA vaccines for emerging infectious diseases: what if? Emer. Infect. Dis. 2, 168-175.
32. Wiktor, T. J., MacFarlan, R. I., Reagan, K. J., Dietzshold, B., Curtis, P. J., Wunner, W. H., Kieny, M.-P., Lathe, R., Lecocq, J.-P., Macket, M., Moss, B. and Koprowski, H. (1984): Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc. Natl. Acad. Sci. USA 81, 7194-7198.
33. Wunner, W. H., Dietzschold, B., Mac Farlan, R. L., Smith, C. L., Golub, E. and Wiktor, T. J. (1985): Localization of immunogenic domains on the rabies virus glycoprotein. Ann. Inst. Pasteur Virology 136 E, 353-362.
34. Wunner, W. H., Larson, J. K., Dietzschold, B. and Smith, C. L. (1988): The molecular biology of rabies virus. Rev. Infect. Dis. 10, S771-S784.
35. Xiang, Z. Q., Spitalnik, S. L., Cheng, J., Erikson, J., Wojczyk, B. and Ertl, C. J. (1995): Immune responses to nucleic acid vaccines to rabies virus. Virology 209, 569-579.
36. Xianhe, B., Warner, C. K. and Fekadu, M. (1993): Comparisons of nucleotide and deduced amino acid sequences of the glycoprotein genes of a Chinese street strain (CGX89-1) and a Chinese vaccine strain (3aG) of rabies virus. Virus Res. 27, 101-112.
37. Yelverton, E., Norton, S., Obijeski, J. F. and Goeddel, D. V. (1983): Rabies virus glycoprotein analogs: biosynthesis in Escherichia coli. Science 219, 614-620.